GRIMES & COMPANY, INC. – Abbott Laboratories Transaction History
GRIMES & COMPANY, INC. portfolio value:
$5.26M
portfolio value
GRIMES & COMPANY, INC. quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.30% | -162 shares | -664K | $96.76 | 54.42K |
| Q2 2022 | share | Increase | +0.21% | 113 shares | -517K | $108.65 | 54.59K |
| Q1 2022 | share | Increase | +0.03% | 14 shares | -1.21M | $118.36 | 54.47K |
| Q4 2021 | share | Decrease | -2.11% | -1.17K shares | 1.09M | $141 | 54.46K |
| Q3 2021 | share | Increase | +0.22% | 122 shares | 136K | $117.68 | 55.63K |
| Q2 2021 | share | Decrease | -0.18% | -98 shares | -229K | $115.05 | 55.51K |
| Q1 2021 | share | Increase | +16.74% | 7.97K shares | 1.44M | $118.49 | 55.61K |
| Q4 2020 | share | 0.00% | 0 shares | 31K | $107.81 | 47.63K | |
| Q3 2020 | share | Decrease | -0.02% | -11 shares | 828K | $106.81 | 47.63K |
| Q2 2020 | share | Increase | +0.12% | 59 shares | 602K | $89.39 | 47.65K |
| Q1 2020 | share | Increase | +4.39% | 2.00K shares | -205K | $76.84 | 47.59K |
| Q4 2019 | share | Increase | +0.35% | 158 shares | 159K | $84.23 | 45.58K |
| Q3 2019 | share | Decrease | -1.20% | -550 shares | -66K | $80.81 | 45.43K |
| Q2 2019 | share | Increase | +0.35% | 161 shares | 204K | $80.92 | 45.98K |
| Q1 2019 | share | Decrease | -0.09% | -39 shares | 346K | $76.6 | 45.81K |
| Q4 2018 | share | Decrease | -0.21% | -95 shares | -54K | $68.98 | 45.85K |
| Q3 2018 | share | Decrease | -0.29% | -133 shares | 560K | $69.69 | 45.95K |
| Q2 2018 | share | Increase | +1.65% | 750 shares | 94K | $57.68 | 46.08K |
| Q1 2018 | share | Increase | +32.57% | 11.13K shares | 765K | $56.4 | 45.33K |
| Q4 2017 | share | Increase | +752.39% | 30.18K shares | 1.73M | $53.46 | 34.19K |
| Q3 2017 | share | Increase | 0.00% | 4.01K shares | 214K | $49.74 | 4.01K |